← FDA Drug Approvals (Drugs@FDA)

RIVASTIGMINE TARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ORBION PHARMS · Approved 2015-06-10

Drug application

FDA Application #

ANDA090879

Application type

Abbreviated New Drug Application (Generic)

Brand name

RIVASTIGMINE TARTRATE

Generic name

Rivastigmine Tartrate

Active ingredients

RIVASTIGMINE TARTRATE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

ORBION PHARMS

First approval

2015-06-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown